Concepedia

Vamsidhar Velcheti

VV

Statistics

Publications

22

Citations

2K

H-Index

19

Active since

2006

Affiliations

NYU Langone Health(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

NYU Langone’s Laura and Isaac Perlmutter Cancer Center

New York University

Yale University

Vamsidhar Velcheti is an author at NYU Langone Health specializing in oncology, cancer immunotherapy, and medicine.

ORCID

Publications per year

2006–2024

22

Publications

22

Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer

Kurt A. Schalper, Jason R. Brown, Daniel Carvajal‐Hausdorf et al. · JNCI Journal of the National Cancer Institute · 2015 · 431 citations · Full text

, , +17

Rational design of anti-GITR-based combination immunotherapy

Roberta Zappasodi, Cynthia A. Sirard, Yanyun Li et al. · Nature Medicine · 2019 · 228 citations · Full text

, , +14

Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma

Maria Vassilakopoulou, Margaritis Avgeris, Vamsidhar Velcheti et al. · Clinical Cancer Research · 2015 · 214 citations

, , +17

Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors

Kim Margolin, Chihiro Morishima, Vamsidhar Velcheti et al. · Clinical Cancer Research · 2018 · 206 citations · Full text

, , +17

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Daniel Carvajal‐Hausdorf, Mehmet Altan, Vamsidhar Velcheti et al. · Journal for ImmunoTherapy of Cancer · 2019 · 203 citations · Full text

, , +17

1–5 of 22